News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,398 Results
Type
Article (40198)
Company Profile (272)
Press Release (662928)
Multimedia
Podcasts (57)
Webinars (12)
Section
Business (205263)
Career Advice (2022)
Deals (35556)
Drug Delivery (97)
Drug Development (81301)
Employer Resources (172)
FDA (16218)
Job Trends (14933)
News (346728)
Policy (32680)
Tag
Academia (2577)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49806)
ALS (90)
Alzheimer's disease (1388)
Antibody-drug conjugate (ADC) (134)
Approvals (16221)
Artificial intelligence (261)
Autoimmune disease (23)
Automation (16)
Bankruptcy (363)
Best Places to Work (11675)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (191)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (284)
Cancer (2293)
Cardiovascular disease (177)
Career advice (1690)
Career pathing (30)
CAR-T (155)
Cell therapy (435)
Cervical cancer (20)
Clinical research (66192)
Collaboration (854)
Company closure (1)
Compensation (551)
Complete response letters (19)
COVID-19 (2606)
CRISPR (42)
C-suite (251)
Cystic fibrosis (100)
Data (2254)
Decentralized trials (2)
Denatured (23)
Depression (43)
Diabetes (274)
Diagnostics (6403)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (95)
Earnings (86925)
Editorial (38)
Employer branding (21)
Employer resources (146)
Events (113788)
Executive appointments (739)
FDA (17526)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (764)
Gene editing (111)
Generative AI (19)
Gene therapy (308)
GLP-1 (716)
Government (4442)
Grass and pollen (4)
Guidances (96)
Healthcare (18870)
Huntington's disease (25)
IgA nephropathy (27)
Immunology and inflammation (122)
Indications (29)
Infectious disease (2751)
Inflammatory bowel disease (147)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (97)
Interviews (311)
IPO (16553)
IRA (42)
Job creations (3668)
Job search strategy (1436)
Kidney cancer (10)
Labor market (38)
Layoffs (478)
Leadership (17)
Legal (7953)
Liver cancer (76)
Lung cancer (323)
Lymphoma (155)
Machine learning (8)
Management (58)
Manufacturing (314)
MASH (69)
Medical device (13403)
Medtech (13408)
Mergers & acquisitions (19555)
Metabolic disorders (697)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1930)
NextGen: Class of 2025 (6568)
Non-profit (4505)
Now hiring (39)
Obesity (369)
Opinion (208)
Ovarian cancer (76)
Pain (90)
Pancreatic cancer (87)
Parkinson's disease (148)
Partnered (21)
Patents (238)
Patient recruitment (113)
Peanut (46)
People (57715)
Pharmaceutical (67)
Pharmacy benefit managers (19)
Phase I (20642)
Phase II (29163)
Phase III (21707)
Pipeline (1257)
Policy (145)
Postmarket research (2566)
Preclinical (8786)
Press Release (64)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (250)
Rare diseases (378)
Real estate (5958)
Recruiting (65)
Regulatory (22389)
Reports (46)
Research institute (2336)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (133)
Series B (86)
Service/supplier (13)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3632)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (43)
The Weekly (32)
Vaccines (695)
Venture capitalists (43)
Weight loss (237)
Women's health (35)
Worklife (16)
Date
Today (168)
Last 7 days (792)
Last 30 days (2820)
Last 365 days (32896)
2025 (11173)
2024 (35382)
2023 (40233)
2022 (51341)
2021 (55897)
2020 (54203)
2019 (46751)
2018 (35207)
2017 (32283)
2016 (31729)
2015 (37779)
2014 (31502)
2013 (26537)
2012 (28838)
2011 (29486)
2010 (27603)
Location
Africa (724)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38163)
Australia (6251)
California (6264)
Canada (2038)
China (531)
Colorado (270)
Connecticut (275)
Delaware (152)
Europe (82027)
Florida (919)
Georgia (207)
Idaho (58)
Illinois (546)
India (26)
Indiana (313)
Iowa (11)
Japan (167)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (902)
Massachusetts (4653)
Michigan (221)
Minnesota (395)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (65)
New Jersey (1748)
New Mexico (28)
New York (1767)
North Carolina (980)
North Dakota (8)
Northern California (2746)
Ohio (209)
Oklahoma (14)
Oregon (35)
Pennsylvania (1395)
Puerto Rico (12)
Rhode Island (33)
South America (1104)
South Carolina (24)
South Dakota (1)
Southern California (2353)
Tennessee (102)
Texas (931)
United States (23510)
Utah (185)
Virginia (149)
Washington D.C. (64)
Washington State (560)
West Virginia (3)
Wisconsin (56)
703,398 Results for "summit biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
Summit’s Campaign To Conquer Keytruda Nears First Global Phase III Data
Keytruda is set to lose exclusivity in 2028, meaning Summit may face competition from cheaper biosimilars. Meanwhile, other branded drugmakers are also seeking to improve on the blockbuster checkpoint inhibitor.
May 7, 2025
·
5 min read
·
Nick Paul Taylor
Lung cancer
Summit’s Bispecific Beats Yet Another Cancer Med, Pressuring Keytruda’s ‘Supremacy’
Analysts at BMO Capital Markets expect Summit and Akeso’s HARMONi-6 readout to put some pressure on Merck and its blockbuster biologic Keytruda.
April 23, 2025
·
2 min read
·
Tristan Manalac
Cancer
Summit, Akeso’s Keytruda Challenger Wins Chinese OK as US Approval Questions Linger
With ivonescimab’s data coming solely from China, its prospects in the U.S., where Summit owns the rights, remain up in the air.
April 28, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Trethera To Participate in Panel Discussion and Research Poster Competition At Los Angeles Bioscience Ecosystem Summit 2025
April 22, 2025
·
4 min read
Press Releases
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
April 8, 2025
·
1 min read
Press Releases
Daré Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women’s Health Innovation
April 23, 2025
·
9 min read
Press Releases
Artelo Biosciences to Present Novel Scientific Insights for ART26.12 at the 4th ACE Drug Discovery Summit on April 3, 2025
April 1, 2025
·
4 min read
Press Releases
Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients
February 27, 2025
·
6 min read
Press Releases
NOK Therapeutics, Inc. to Attend 10th Annual Innate Killer Summit in San Diego
February 26, 2025
·
1 min read
Press Releases
Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the LSI USA ’25 Emerging Medtech Summit
February 27, 2025
·
1 min read
1 of 70,340
Next
